Tag: T1D

glucometer, technology, device

T1D – Zucara Therapeutics Doses First Patients in Phase 1b Trial of ZT-01

– Proof-of-Concept Trial to Evaluate the Effect of ZT-01 on Insulin-Induced Hypoglycemia in Patients with Type 1 Diabetes – TORONTO, July 28, 2021 /PRNewswire/ – Zucara Therapeutics Inc., a diabetes life sciences company developing the first once-daily therapeutic to prevent insulin-induced hypoglycemia (low blood glucose levels), today announced that it has dosed the […]

#ADA2021 Success! #ViaCyte Reports Compelling Preliminary Clinical Data from Islet Cell Replacement Therapy for Patients with Type 1 Diabetes

– PEC-Direct (VC-02) demonstrates first instance showing glucose-responsive insulin production, C-peptide of 0.8 ng/mL, from implanted pancreatic progenitor cells in humans – – Therapeutic effect showing increase to 88% time in range with corresponding reduction of HbA1C from 7.4% to 6.6% – – Late-breaking results presented at the […]

love, heart, icon

#DITECI Fai la tua parte: T1D e impatto della tecnologia sul vivere quotidiano

La ricerca DITECI, dapprima soltanto per i giovani adulti dai 18 ai 25 anni, è stata adesso estesa alle persone con diabete di tipo 1 con più di 25 anni. La ricerca si propone di indagare il benessere psicologico delle persone con diabete di tipo 1 che hanno un’età […]

University of Miami Diabetes Research Institute Launches Trial of Novel Investigational Treatment for Type 1 Diabetes

Researchers with the Diabetes Research Institute (DRI) at the University of Miami Miller School of Medicine and Vertex Pharmaceuticals Incorporated have initiated clinical trials for VX-880, a novel investigational cell therapy with the potential to restore normal glucose control in people suffering from type 1 diabetes with severe hypoglycemia and impaired hypoglycemic […]

Il sistema ibrido a circuito chiuso non rappresenta un carico maggiore per i bambini con diabete di tipo 1

Erin C. Cobry, MD , assistente professore di pediatria presso il Barbara Davis Center for Childhood Diabetes, University of Colorado Anschutz Medical Campus, e colleghi non hanno osservato differenze significative nella paura dell’ipoglicemia, stress correlato al diabete e altri risultati auto-riportati per lo studio partecipanti che utilizzano un microinfusore […]

%d blogger hanno fatto clic su Mi Piace per questo: